Sun Pharmaceutical Industries Ltd. closed 10.67% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...

Emkay Global maintains a 'Buy' rating on Sun Pharma after the US Court of Appeals vacates the injunction against Leqselvi's ...

The rise in the Sun Pharma share price came after a favourable ruling from a US court regarding its planned launch of ...

Sun Pharmaceutical Industries on Thursday said that it has received a major relief from a US court, which allowed it to ...

"While the litigation between Incyte Corporation and the company continues, the preliminary injunction is no longer in effect ...

After a legal decision delayed its entry last fall, Sun Pharma has received the all-clear to tap into the U.S. | After Sun ...

On Thursday, April 10, Sun Pharma announced that the U.S. Court of Appeals for the Federal Circuit has vacated a preliminary ...

Sun Pharmaceutical Industries Ltd on Thursday said a US court has ruled in its favour and vacated a preliminary injunction ...

Sun Pharmaceuticals Industries Ltd on Thursday, April 10 said the US Court of Appeals for the Federal Circuit has ruled in ...